ログイン

biopharmaceutics

biopharmaceutics
74問 • 1年前
  • Hannah Angelique Losaria
  • 通報

    問題一覧

  • 1

    Drug concentration at t=0 (drug- IV)

    the cmax was achieved

  • 2

    The onset time corresponds to time when

    the MEC was first reached

  • 3

    For a drug to exert its pharmacologic activity the plasma concentration should

    within the therapeutic window

  • 4

    The tmax is when

    the Cmax was achieved

  • 5

    The duration of action is when

    plasma drug concentration was within the therapeutic window

  • 6

    Most important and most common parenteral parenteral administration route- into the peripheral vein

    intravenous

  • 7

    IV given in large dose dissolved in a vehicle

    bolus

  • 8

    IV given over a period

    infusion

  • 9

    Into the artery

    intraarterial

  • 10

    Use of intraarterial

    chemotherapy

  • 11

    Into the heart chamber - heart muscles and ventricles

    intracardiac

  • 12

    The most common extravascular route * The drug undergoes complete first pass effect

    oral

  • 13

    Phenomenon of a drug metabolism whereby the concentration of the drug is greatly reduced before it reaches the systemic circulation

    first pass effect

  • 14

    Placement of drug under the tongue *Bypass the first pass effect

    sublingual

  • 15

    Drug is placed between cheeks and gums

    buccal

  • 16

    Intramuscular is the only route that permits _________ volume of fluid

    large

  • 17

    Common sites of intramuscular injection

    deltoid, buttocks, thighs

  • 18

    Delivery of drug deep into the muscle is called ___________ effect

    depot

  • 19

    Tissue damage caused by subcutaneous injection

    lipodystrophy

  • 20

    Only takes effect at the site of administration

    local effect

  • 21

    2 layers of phospholipids between two surface layers of protein The hydrophilic head groups of the phospholipids facing the protein layers and the hydrophobic tail groups aligned in the interior.- semipermeable membrane

    membrane physiology factor

  • 22

    Injected directly into the spine

    intrathecal

  • 23

    The ______________ head groups of the phospholipids facing the protein layers and the __________________ tail groups aligned in the interior. -semi permeable membrane

    hydrophilic, hydrophobic

  • 24

    Numerical valve that reflect the needle diameter. The higher the number, the smaller the diameter

    gauge

  • 25

    Easy passage

    luna

  • 26

    Difficult passage

    hipe

  • 27

    States that ionizable compounds penetrate biological membranes primarily in the unionized form

    ph partition theory

  • 28

    In ph partition theory, the ionizable compounds penetrate biological membranes primarily in the ___________ forms

    unionized

  • 29

    Acidic drugs are best absorbed at ____________ ph

    acidic/ low

  • 30

    Basic drugs are best absorbed at _______________ ph

    basic/ high

  • 31

    In Ph partition theory, despite their high degree of ionization (ph < pka), weak acids are highly absorbed in small intestine. Why?

    large surface area, high contact time

  • 32

    Ratio of drug solubility (at equilibrium) in a non-aqueous solvent (n-octanol) to that in an aqueous solvent (water, ph 7.4 buffer solution)

    partition coeffecient

  • 33

    Balance between hydrophillic and lipophillic

    partition coefficient

  • 34

    Dissolution rate is governed by

    noyes whitney equation

  • 35

    Rate limiting step in drug absorption

    dissolution

  • 36

    Process by which a solid drug substance is dissolved in a solvent over time

    dissolution

  • 37

    ___________ particle size, ___________ surface area, ______________ dissolution rate

    smaller, higher, faster

  • 38

    Two types of crystal forms

    amorphous, crystalline

  • 39

    Irregular shape Less stable Faster rate of dissolution

    amorphous

  • 40

    Regular shape More stable Slower dissolution rate

    crystalline

  • 41

    Crystal forms or

    polymorphs

  • 42

    Other term for solvates

    polymorphs

  • 43

    Crystal formation after addition of solvent

    polymorphs

  • 44

    What does polymorphism affect

    stability, solubility, dissolution rate, etc

  • 45

    Arrangement of a drug substance in various molecular packing (crystal forms)

    polymorphism

  • 46

    Drugs susceptible to acid have reduced bioavailability

    stability (stomach)

  • 47

    Refers to any combination with the drug that results to altered properties

    drug interaction

  • 48

    Drug interaction is also known as

    complexation

  • 49

    Excipient factors

    lubricants, disintegrants, coatings

  • 50

    Excipient factor that is hydrophobic = reduced dissolution

    lubricants

  • 51

    Excipient factors: Less disintegrant = reduced dissolution

    disintegrants

  • 52

    Excipient factors: Provides protection= prevents drug inactivation or degradation in the stomach

    coatings

  • 53

    Ldf have _______________ rate of absorption than sdf

    higher/ faster

  • 54

    The ability of the drug to be absorbed and used by the body

    bioavailability

  • 55

    Bioavailability is the _______ and _________ at which drug enters the ___________________________ thereby accessing the site of action

    rate, extent, systemic circulation

  • 56

    Bioavailability is the ____________ (relative amount) of drug that reaches the general circulation

    fraction

  • 57

    auc measures the _________________ of drug in the body

    quantity

  • 58

    auc measures the ______________ of bioavailability

    extent

  • 59

    What rule is associated with auc

    trapezoidal rule

  • 60

    Trapezoidal rule compute the ___________ of each trapezoid

    area

  • 61

    Types of bioavailability

    relative, absolute

  • 62

    •comparison of non IV dosage forms •oral solution vs oral tablets

    relative bioavailability

  • 63

    •non iv vs iv Standard: IV because it has 100%F

    absolute bioavailability

  • 64

    Refers to the comparison of bioavailabilities of different formulations, drug products, or batches of the same drug products -established when two drugs have similar BA

    bioequivalence

  • 65

    Bioequivalence measure the ___________ ratio, ________ ratio, and ________ ratio

    auc, cmax, tmax

  • 66

    Process of dispensing different brand or unbranded drug product in place of the prescribed drug product

    generic substitution

  • 67

    In drug substitution, substituted drug must have the same ______________, but differ in _____________

    therapeutic moiety, manufacturer

  • 68

    Process of dispensing pharmaceutical alternative for the prescribed drug product

    pharmaceutical substitution

  • 69

    Same API Different salt, esters, complex, dosage forms

    pharmaceutic alternative

  • 70

    Example of phrmaceutical alternative

    tetracycline hcl and tetracycline po4

  • 71

    Same api, salt, ester, complex, dosage form, quality Different shape, release mechanism, packaging,excipients, labeling

    pharmaceutic equivalent

  • 72

    Same therapeutic category Different generic name

    therapeutic alternative

  • 73

    Example of therapeutic alternative

    ranitidine, cemitidine

  • 74

    •safe and effective •pharma equivalents •they are bioequivalents •adequately labeled •compliant with cgmp guidelines

    therapeutic equivalent

  • gastro

    gastro

    Hannah Angelique Losaria · 100問 · 2年前

    gastro

    gastro

    100問 • 2年前
    Hannah Angelique Losaria

    gastro m

    gastro m

    Hannah Angelique Losaria · 7問 · 2年前

    gastro m

    gastro m

    7問 • 2年前
    Hannah Angelique Losaria

    lab

    lab

    Hannah Angelique Losaria · 13問 · 2年前

    lab

    lab

    13問 • 2年前
    Hannah Angelique Losaria

    m2

    m2

    Hannah Angelique Losaria · 94問 · 2年前

    m2

    m2

    94問 • 2年前
    Hannah Angelique Losaria

    m1

    m1

    Hannah Angelique Losaria · 88問 · 2年前

    m1

    m1

    88問 • 2年前
    Hannah Angelique Losaria

    poisons

    poisons

    Hannah Angelique Losaria · 50問 · 2年前

    poisons

    poisons

    50問 • 2年前
    Hannah Angelique Losaria

    lec

    lec

    Hannah Angelique Losaria · 19問 · 2年前

    lec

    lec

    19問 • 2年前
    Hannah Angelique Losaria

    exam

    exam

    Hannah Angelique Losaria · 16問 · 2年前

    exam

    exam

    16問 • 2年前
    Hannah Angelique Losaria

    spec

    spec

    Hannah Angelique Losaria · 41問 · 1年前

    spec

    spec

    41問 • 1年前
    Hannah Angelique Losaria

    midterm

    midterm

    Hannah Angelique Losaria · 55問 · 1年前

    midterm

    midterm

    55問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    Hannah Angelique Losaria · 54問 · 1年前

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    54問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    Hannah Angelique Losaria · 29問 · 1年前

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    29問 • 1年前
    Hannah Angelique Losaria

    DDS

    DDS

    Hannah Angelique Losaria · 33問 · 1年前

    DDS

    DDS

    33問 • 1年前
    Hannah Angelique Losaria

    hallucinogens

    hallucinogens

    Hannah Angelique Losaria · 22問 · 1年前

    hallucinogens

    hallucinogens

    22問 • 1年前
    Hannah Angelique Losaria

    non volatile poisons

    non volatile poisons

    Hannah Angelique Losaria · 42問 · 1年前

    non volatile poisons

    non volatile poisons

    42問 • 1年前
    Hannah Angelique Losaria

    endterm

    endterm

    Hannah Angelique Losaria · 63問 · 1年前

    endterm

    endterm

    63問 • 1年前
    Hannah Angelique Losaria

    q3 endterm

    q3 endterm

    Hannah Angelique Losaria · 17問 · 1年前

    q3 endterm

    q3 endterm

    17問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019

    mockboard 2019

    Hannah Angelique Losaria · 65問 · 1年前

    mockboard 2019

    mockboard 2019

    65問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019 II

    mockboard 2019 II

    Hannah Angelique Losaria · 39問 · 1年前

    mockboard 2019 II

    mockboard 2019 II

    39問 • 1年前
    Hannah Angelique Losaria

    miss mel reviewer

    miss mel reviewer

    Hannah Angelique Losaria · 36問 · 1年前

    miss mel reviewer

    miss mel reviewer

    36問 • 1年前
    Hannah Angelique Losaria

    miss roma high yield

    miss roma high yield

    Hannah Angelique Losaria · 9問 · 1年前

    miss roma high yield

    miss roma high yield

    9問 • 1年前
    Hannah Angelique Losaria

    micro highlights

    micro highlights

    Hannah Angelique Losaria · 12問 · 1年前

    micro highlights

    micro highlights

    12問 • 1年前
    Hannah Angelique Losaria

    module 6 AUgdguwegfiuwegfu

    module 6 AUgdguwegfiuwegfu

    Hannah Angelique Losaria · 24問 · 1年前

    module 6 AUgdguwegfiuwegfu

    module 6 AUgdguwegfiuwegfu

    24問 • 1年前
    Hannah Angelique Losaria

    mod6 sure

    mod6 sure

    Hannah Angelique Losaria · 75問 · 1年前

    mod6 sure

    mod6 sure

    75問 • 1年前
    Hannah Angelique Losaria

    manufacturing

    manufacturing

    Hannah Angelique Losaria · 100問 · 1年前

    manufacturing

    manufacturing

    100問 • 1年前
    Hannah Angelique Losaria

    module 5

    module 5

    Hannah Angelique Losaria · 94問 · 1年前

    module 5

    module 5

    94問 • 1年前
    Hannah Angelique Losaria

    mod5

    mod5

    Hannah Angelique Losaria · 98問 · 1年前

    mod5

    mod5

    98問 • 1年前
    Hannah Angelique Losaria

    5555555555

    5555555555

    Hannah Angelique Losaria · 100問 · 1年前

    5555555555

    5555555555

    100問 • 1年前
    Hannah Angelique Losaria

    brex

    brex

    Hannah Angelique Losaria · 100問 · 1年前

    brex

    brex

    100問 • 1年前
    Hannah Angelique Losaria

    mod4

    mod4

    Hannah Angelique Losaria · 44問 · 1年前

    mod4

    mod4

    44問 • 1年前
    Hannah Angelique Losaria

    tox lab

    tox lab

    Hannah Angelique Losaria · 69問 · 1年前

    tox lab

    tox lab

    69問 • 1年前
    Hannah Angelique Losaria

    biopharmaceutics

    biopharmaceutics

    Hannah Angelique Losaria · 59問 · 1年前

    biopharmaceutics

    biopharmaceutics

    59問 • 1年前
    Hannah Angelique Losaria

    toxicology

    toxicology

    Hannah Angelique Losaria · 86問 · 1年前

    toxicology

    toxicology

    86問 • 1年前
    Hannah Angelique Losaria

    non volatile

    non volatile

    Hannah Angelique Losaria · 49問 · 1年前

    non volatile

    non volatile

    49問 • 1年前
    Hannah Angelique Losaria

    gosel and bricker

    gosel and bricker

    Hannah Angelique Losaria · 15問 · 1年前

    gosel and bricker

    gosel and bricker

    15問 • 1年前
    Hannah Angelique Losaria

    management of ADRs bariles

    management of ADRs bariles

    Hannah Angelique Losaria · 19問 · 1年前

    management of ADRs bariles

    management of ADRs bariles

    19問 • 1年前
    Hannah Angelique Losaria

    quiz 4

    quiz 4

    Hannah Angelique Losaria · 16問 · 1年前

    quiz 4

    quiz 4

    16問 • 1年前
    Hannah Angelique Losaria

    pcol miss gift exam

    pcol miss gift exam

    Hannah Angelique Losaria · 63問 · 1年前

    pcol miss gift exam

    pcol miss gift exam

    63問 • 1年前
    Hannah Angelique Losaria

    expirement 2- antidotes

    expirement 2- antidotes

    Hannah Angelique Losaria · 27問 · 1年前

    expirement 2- antidotes

    expirement 2- antidotes

    27問 • 1年前
    Hannah Angelique Losaria

    volatile poisons

    volatile poisons

    Hannah Angelique Losaria · 28問 · 1年前

    volatile poisons

    volatile poisons

    28問 • 1年前
    Hannah Angelique Losaria

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    Hannah Angelique Losaria · 37問 · 1年前

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    37問 • 1年前
    Hannah Angelique Losaria

    anti arrhythmic drugs

    anti arrhythmic drugs

    Hannah Angelique Losaria · 20問 · 1年前

    anti arrhythmic drugs

    anti arrhythmic drugs

    20問 • 1年前
    Hannah Angelique Losaria

    antiplatelet drugs

    antiplatelet drugs

    Hannah Angelique Losaria · 17問 · 1年前

    antiplatelet drugs

    antiplatelet drugs

    17問 • 1年前
    Hannah Angelique Losaria

    Cardiovascular Drugs

    Cardiovascular Drugs

    Hannah Angelique Losaria · 31問 · 1年前

    Cardiovascular Drugs

    Cardiovascular Drugs

    31問 • 1年前
    Hannah Angelique Losaria

    barbiturates

    barbiturates

    Hannah Angelique Losaria · 26問 · 1年前

    barbiturates

    barbiturates

    26問 • 1年前
    Hannah Angelique Losaria

    physical pharmacy

    physical pharmacy

    Hannah Angelique Losaria · 34問 · 1年前

    physical pharmacy

    physical pharmacy

    34問 • 1年前
    Hannah Angelique Losaria

    plasma

    plasma

    Hannah Angelique Losaria · 10問 · 1年前

    plasma

    plasma

    10問 • 1年前
    Hannah Angelique Losaria

    endterm

    endterm

    Hannah Angelique Losaria · 73問 · 1年前

    endterm

    endterm

    73問 • 1年前
    Hannah Angelique Losaria

    juris

    juris

    Hannah Angelique Losaria · 55問 · 1年前

    juris

    juris

    55問 • 1年前
    Hannah Angelique Losaria

    dds

    dds

    Hannah Angelique Losaria · 100問 · 1年前

    dds

    dds

    100問 • 1年前
    Hannah Angelique Losaria

    55

    55

    Hannah Angelique Losaria · 92問 · 1年前

    55

    55

    92問 • 1年前
    Hannah Angelique Losaria

    dddssss

    dddssss

    Hannah Angelique Losaria · 19問 · 1年前

    dddssss

    dddssss

    19問 • 1年前
    Hannah Angelique Losaria

    manuf

    manuf

    Hannah Angelique Losaria · 59問 · 1年前

    manuf

    manuf

    59問 • 1年前
    Hannah Angelique Losaria

    qc/qa

    qc/qa

    Hannah Angelique Losaria · 67問 · 1年前

    qc/qa

    qc/qa

    67問 • 1年前
    Hannah Angelique Losaria

    qc qa identification

    qc qa identification

    Hannah Angelique Losaria · 83問 · 1年前

    qc qa identification

    qc qa identification

    83問 • 1年前
    Hannah Angelique Losaria

    quali/ quanti ppt

    quali/ quanti ppt

    Hannah Angelique Losaria · 100問 · 1年前

    quali/ quanti ppt

    quali/ quanti ppt

    100問 • 1年前
    Hannah Angelique Losaria

    quali/quanti 2

    quali/quanti 2

    Hannah Angelique Losaria · 23問 · 1年前

    quali/quanti 2

    quali/quanti 2

    23問 • 1年前
    Hannah Angelique Losaria

    quali quanti identification

    quali quanti identification

    Hannah Angelique Losaria · 68問 · 1年前

    quali quanti identification

    quali quanti identification

    68問 • 1年前
    Hannah Angelique Losaria

    microbiology: introduction and bacterial anatomy

    microbiology: introduction and bacterial anatomy

    Hannah Angelique Losaria · 37問 · 1年前

    microbiology: introduction and bacterial anatomy

    microbiology: introduction and bacterial anatomy

    37問 • 1年前
    Hannah Angelique Losaria

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    Hannah Angelique Losaria · 60問 · 1年前

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    mocrobiology: bacterial stain, nutrition, bacterial recombination, growth phrases, microbial growth factor, culture media

    60問 • 1年前
    Hannah Angelique Losaria

    microbiology: bacteriology part 1

    microbiology: bacteriology part 1

    Hannah Angelique Losaria · 28問 · 1年前

    microbiology: bacteriology part 1

    microbiology: bacteriology part 1

    28問 • 1年前
    Hannah Angelique Losaria

    microbiology: bacteriology part 2

    microbiology: bacteriology part 2

    Hannah Angelique Losaria · 48問 · 1年前

    microbiology: bacteriology part 2

    microbiology: bacteriology part 2

    48問 • 1年前
    Hannah Angelique Losaria

    microbiology: mycology

    microbiology: mycology

    Hannah Angelique Losaria · 20問 · 1年前

    microbiology: mycology

    microbiology: mycology

    20問 • 1年前
    Hannah Angelique Losaria

    microbio identification 1

    microbio identification 1

    Hannah Angelique Losaria · 48問 · 1年前

    microbio identification 1

    microbio identification 1

    48問 • 1年前
    Hannah Angelique Losaria

    miss gift

    miss gift

    Hannah Angelique Losaria · 38問 · 1年前

    miss gift

    miss gift

    38問 • 1年前
    Hannah Angelique Losaria

    microbiology 2

    microbiology 2

    Hannah Angelique Losaria · 21問 · 1年前

    microbiology 2

    microbiology 2

    21問 • 1年前
    Hannah Angelique Losaria

    microbio 3

    microbio 3

    Hannah Angelique Losaria · 18問 · 1年前

    microbio 3

    microbio 3

    18問 • 1年前
    Hannah Angelique Losaria

    microbio 4

    microbio 4

    Hannah Angelique Losaria · 10問 · 1年前

    microbio 4

    microbio 4

    10問 • 1年前
    Hannah Angelique Losaria

    microbio anatomy

    microbio anatomy

    Hannah Angelique Losaria · 30問 · 1年前

    microbio anatomy

    microbio anatomy

    30問 • 1年前
    Hannah Angelique Losaria

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    Hannah Angelique Losaria · 37問 · 1年前

    Drugs acting on the central nercous sytem

    Drugs acting on the central nercous sytem

    37問 • 1年前
    Hannah Angelique Losaria

    microbio5

    microbio5

    Hannah Angelique Losaria · 17問 · 1年前

    microbio5

    microbio5

    17問 • 1年前
    Hannah Angelique Losaria

    microbio6

    microbio6

    Hannah Angelique Losaria · 13問 · 1年前

    microbio6

    microbio6

    13問 • 1年前
    Hannah Angelique Losaria

    pub health 1

    pub health 1

    Hannah Angelique Losaria · 34問 · 1年前

    pub health 1

    pub health 1

    34問 • 1年前
    Hannah Angelique Losaria

    microbio7

    microbio7

    Hannah Angelique Losaria · 30問 · 1年前

    microbio7

    microbio7

    30問 • 1年前
    Hannah Angelique Losaria

    public health

    public health

    Hannah Angelique Losaria · 31問 · 1年前

    public health

    public health

    31問 • 1年前
    Hannah Angelique Losaria

    pacop

    pacop

    Hannah Angelique Losaria · 40問 · 1年前

    pacop

    pacop

    40問 • 1年前
    Hannah Angelique Losaria

    inorganic pharmaceutical pharmacy

    inorganic pharmaceutical pharmacy

    Hannah Angelique Losaria · 98問 · 1年前

    inorganic pharmaceutical pharmacy

    inorganic pharmaceutical pharmacy

    98問 • 1年前
    Hannah Angelique Losaria

    transition metal iron triad FE CO NI

    transition metal iron triad FE CO NI

    Hannah Angelique Losaria · 10問 · 1年前

    transition metal iron triad FE CO NI

    transition metal iron triad FE CO NI

    10問 • 1年前
    Hannah Angelique Losaria

    licensing

    licensing

    Hannah Angelique Losaria · 8問 · 1年前

    licensing

    licensing

    8問 • 1年前
    Hannah Angelique Losaria

    most common side effects

    most common side effects

    Hannah Angelique Losaria · 26問 · 1年前

    most common side effects

    most common side effects

    26問 • 1年前
    Hannah Angelique Losaria

    chemistry people

    chemistry people

    Hannah Angelique Losaria · 10問 · 1年前

    chemistry people

    chemistry people

    10問 • 1年前
    Hannah Angelique Losaria

    pharmacognosy people

    pharmacognosy people

    Hannah Angelique Losaria · 10問 · 1年前

    pharmacognosy people

    pharmacognosy people

    10問 • 1年前
    Hannah Angelique Losaria

    drug of choice

    drug of choice

    Hannah Angelique Losaria · 29問 · 1年前

    drug of choice

    drug of choice

    29問 • 1年前
    Hannah Angelique Losaria

    common antidotes

    common antidotes

    Hannah Angelique Losaria · 19問 · 1年前

    common antidotes

    common antidotes

    19問 • 1年前
    Hannah Angelique Losaria

    vitamin functions and deficiencies

    vitamin functions and deficiencies

    Hannah Angelique Losaria · 25問 · 1年前

    vitamin functions and deficiencies

    vitamin functions and deficiencies

    25問 • 1年前
    Hannah Angelique Losaria

    inorganic pharmaceutical pharmacy 2

    inorganic pharmaceutical pharmacy 2

    Hannah Angelique Losaria · 97問 · 1年前

    inorganic pharmaceutical pharmacy 2

    inorganic pharmaceutical pharmacy 2

    97問 • 1年前
    Hannah Angelique Losaria

    1

    1

    Hannah Angelique Losaria · 100問 · 1年前

    1

    1

    100問 • 1年前
    Hannah Angelique Losaria

    2

    2

    Hannah Angelique Losaria · 42問 · 1年前

    2

    2

    42問 • 1年前
    Hannah Angelique Losaria

    1

    1

    Hannah Angelique Losaria · 62問 · 1年前

    1

    1

    62問 • 1年前
    Hannah Angelique Losaria

    inorganic pharm chem 3

    inorganic pharm chem 3

    Hannah Angelique Losaria · 48問 · 1年前

    inorganic pharm chem 3

    inorganic pharm chem 3

    48問 • 1年前
    Hannah Angelique Losaria

    2

    2

    Hannah Angelique Losaria · 66問 · 1年前

    2

    2

    66問 • 1年前
    Hannah Angelique Losaria

    3

    3

    Hannah Angelique Losaria · 60問 · 1年前

    3

    3

    60問 • 1年前
    Hannah Angelique Losaria

    4

    4

    Hannah Angelique Losaria · 43問 · 1年前

    4

    4

    43問 • 1年前
    Hannah Angelique Losaria

    1

    1

    Hannah Angelique Losaria · 100問 · 1年前

    1

    1

    100問 • 1年前
    Hannah Angelique Losaria

    2

    2

    Hannah Angelique Losaria · 100問 · 1年前

    2

    2

    100問 • 1年前
    Hannah Angelique Losaria

    3

    3

    Hannah Angelique Losaria · 79問 · 1年前

    3

    3

    79問 • 1年前
    Hannah Angelique Losaria

    問題一覧

  • 1

    Drug concentration at t=0 (drug- IV)

    the cmax was achieved

  • 2

    The onset time corresponds to time when

    the MEC was first reached

  • 3

    For a drug to exert its pharmacologic activity the plasma concentration should

    within the therapeutic window

  • 4

    The tmax is when

    the Cmax was achieved

  • 5

    The duration of action is when

    plasma drug concentration was within the therapeutic window

  • 6

    Most important and most common parenteral parenteral administration route- into the peripheral vein

    intravenous

  • 7

    IV given in large dose dissolved in a vehicle

    bolus

  • 8

    IV given over a period

    infusion

  • 9

    Into the artery

    intraarterial

  • 10

    Use of intraarterial

    chemotherapy

  • 11

    Into the heart chamber - heart muscles and ventricles

    intracardiac

  • 12

    The most common extravascular route * The drug undergoes complete first pass effect

    oral

  • 13

    Phenomenon of a drug metabolism whereby the concentration of the drug is greatly reduced before it reaches the systemic circulation

    first pass effect

  • 14

    Placement of drug under the tongue *Bypass the first pass effect

    sublingual

  • 15

    Drug is placed between cheeks and gums

    buccal

  • 16

    Intramuscular is the only route that permits _________ volume of fluid

    large

  • 17

    Common sites of intramuscular injection

    deltoid, buttocks, thighs

  • 18

    Delivery of drug deep into the muscle is called ___________ effect

    depot

  • 19

    Tissue damage caused by subcutaneous injection

    lipodystrophy

  • 20

    Only takes effect at the site of administration

    local effect

  • 21

    2 layers of phospholipids between two surface layers of protein The hydrophilic head groups of the phospholipids facing the protein layers and the hydrophobic tail groups aligned in the interior.- semipermeable membrane

    membrane physiology factor

  • 22

    Injected directly into the spine

    intrathecal

  • 23

    The ______________ head groups of the phospholipids facing the protein layers and the __________________ tail groups aligned in the interior. -semi permeable membrane

    hydrophilic, hydrophobic

  • 24

    Numerical valve that reflect the needle diameter. The higher the number, the smaller the diameter

    gauge

  • 25

    Easy passage

    luna

  • 26

    Difficult passage

    hipe

  • 27

    States that ionizable compounds penetrate biological membranes primarily in the unionized form

    ph partition theory

  • 28

    In ph partition theory, the ionizable compounds penetrate biological membranes primarily in the ___________ forms

    unionized

  • 29

    Acidic drugs are best absorbed at ____________ ph

    acidic/ low

  • 30

    Basic drugs are best absorbed at _______________ ph

    basic/ high

  • 31

    In Ph partition theory, despite their high degree of ionization (ph < pka), weak acids are highly absorbed in small intestine. Why?

    large surface area, high contact time

  • 32

    Ratio of drug solubility (at equilibrium) in a non-aqueous solvent (n-octanol) to that in an aqueous solvent (water, ph 7.4 buffer solution)

    partition coeffecient

  • 33

    Balance between hydrophillic and lipophillic

    partition coefficient

  • 34

    Dissolution rate is governed by

    noyes whitney equation

  • 35

    Rate limiting step in drug absorption

    dissolution

  • 36

    Process by which a solid drug substance is dissolved in a solvent over time

    dissolution

  • 37

    ___________ particle size, ___________ surface area, ______________ dissolution rate

    smaller, higher, faster

  • 38

    Two types of crystal forms

    amorphous, crystalline

  • 39

    Irregular shape Less stable Faster rate of dissolution

    amorphous

  • 40

    Regular shape More stable Slower dissolution rate

    crystalline

  • 41

    Crystal forms or

    polymorphs

  • 42

    Other term for solvates

    polymorphs

  • 43

    Crystal formation after addition of solvent

    polymorphs

  • 44

    What does polymorphism affect

    stability, solubility, dissolution rate, etc

  • 45

    Arrangement of a drug substance in various molecular packing (crystal forms)

    polymorphism

  • 46

    Drugs susceptible to acid have reduced bioavailability

    stability (stomach)

  • 47

    Refers to any combination with the drug that results to altered properties

    drug interaction

  • 48

    Drug interaction is also known as

    complexation

  • 49

    Excipient factors

    lubricants, disintegrants, coatings

  • 50

    Excipient factor that is hydrophobic = reduced dissolution

    lubricants

  • 51

    Excipient factors: Less disintegrant = reduced dissolution

    disintegrants

  • 52

    Excipient factors: Provides protection= prevents drug inactivation or degradation in the stomach

    coatings

  • 53

    Ldf have _______________ rate of absorption than sdf

    higher/ faster

  • 54

    The ability of the drug to be absorbed and used by the body

    bioavailability

  • 55

    Bioavailability is the _______ and _________ at which drug enters the ___________________________ thereby accessing the site of action

    rate, extent, systemic circulation

  • 56

    Bioavailability is the ____________ (relative amount) of drug that reaches the general circulation

    fraction

  • 57

    auc measures the _________________ of drug in the body

    quantity

  • 58

    auc measures the ______________ of bioavailability

    extent

  • 59

    What rule is associated with auc

    trapezoidal rule

  • 60

    Trapezoidal rule compute the ___________ of each trapezoid

    area

  • 61

    Types of bioavailability

    relative, absolute

  • 62

    •comparison of non IV dosage forms •oral solution vs oral tablets

    relative bioavailability

  • 63

    •non iv vs iv Standard: IV because it has 100%F

    absolute bioavailability

  • 64

    Refers to the comparison of bioavailabilities of different formulations, drug products, or batches of the same drug products -established when two drugs have similar BA

    bioequivalence

  • 65

    Bioequivalence measure the ___________ ratio, ________ ratio, and ________ ratio

    auc, cmax, tmax

  • 66

    Process of dispensing different brand or unbranded drug product in place of the prescribed drug product

    generic substitution

  • 67

    In drug substitution, substituted drug must have the same ______________, but differ in _____________

    therapeutic moiety, manufacturer

  • 68

    Process of dispensing pharmaceutical alternative for the prescribed drug product

    pharmaceutical substitution

  • 69

    Same API Different salt, esters, complex, dosage forms

    pharmaceutic alternative

  • 70

    Example of phrmaceutical alternative

    tetracycline hcl and tetracycline po4

  • 71

    Same api, salt, ester, complex, dosage form, quality Different shape, release mechanism, packaging,excipients, labeling

    pharmaceutic equivalent

  • 72

    Same therapeutic category Different generic name

    therapeutic alternative

  • 73

    Example of therapeutic alternative

    ranitidine, cemitidine

  • 74

    •safe and effective •pharma equivalents •they are bioequivalents •adequately labeled •compliant with cgmp guidelines

    therapeutic equivalent